Adpkd clinical trials

Explore recruiting adpkd clinical trials.

Recruiting adpkd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Adpkd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

STOP-PKD: SGLT2-inhibition to improve Prognosis in Polycystic Kidney Disease

Netherlands, Austria, Spain, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Safety of rotigotine in patients with autosomal dominant polycystic kidney disease - ETERNAL-PKD

France

Therapeutic exploratory (Phase II) EU CTIS Study details

HYDROchlorothiazide to PROTECT polycystic kidney disease patients and improve their quality of life (HYDRO-PROTECT)

Spain, France, Netherlands, Belgium, Germany, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Treatment of vascular stiffness in patients with autosomal dominant polycystic kidney disease

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Metformin versus Tolvaptan in adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD): a phase 3a, independent, multi- centre, 2 parallel arms randomized controlled trial

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2a, Open-label, Single-arm Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VX-407 in Subjects with Autosomal Dominant Polycystic Kidney Disease Who Have a Subset of PKD1 Gene Variants

France, Germany, Italy, Belgium, Spain, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Adpkd trials by city

Adpkd in Toronto Adpkd in Vancouver Adpkd in Montreal Adpkd in Calgary Adpkd in Edmonton Adpkd in Ottawa Adpkd in Winnipeg Adpkd in Quebec City Adpkd in Hamilton Adpkd in Kitchener Adpkd in London Adpkd in Halifax Adpkd in New York Adpkd in Los Angeles Adpkd in Chicago Adpkd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease